In cutaneous melanoma, the presence of a TERT promoter mutation in addition to a BRAF mutation is associated with unfavorable clinicopathological characteristics, such as large tumor thickness and a high mitotic rate [26]. This evidence concerns the gene BRAF and cutaneous melanoma.